Last Updated: Wednesday, January 16, 2013
Principal Investigator: Jeremy M. Veenstra-VanderWeele, M.D.
Other researchers: Cassandra Newsom, PhD Kevin Sanders, MD
Do you have a family member that has been diagnosed with Fragile X Syndrome?
We invite adults age 16– 50 for a study using an investigational drug. The purpose of the study is to try and find out if this medication is safe and helpful for patients with Fragile X syndrome. This is a randomized, double-blind, 12- week, parallel group, placebo controlled study of the efficacy and safety of RO4917523 in patients with Fragile X syndrome.
You will be asked to come for 7 visits to Vanderbilt University in Nashville, TN. to take part in this research study. A blood draw is required at 7 separate visits.
Adults age 16– 50 with Fragile X for a study using an investigational drug.
Evaluations, study visits, and study drug are provided at no cost. Compensation for transportation will be provided.
7 visits to Vanderbilt University in Nashville, TN.
Sarah Marler
615-936-3288
sarah.marler@vanderbilt.edu
Adults 18-45 with Fragile X syndrome
Compensation: YesAdolescents (12-17 years old) with Fragile X syndrome
Compensation: YesAdolescents and young adults (12-25 years old) with Fragile X syndrome
Compensation: YesChildren with a confirmed diagnosis of Fragile X between 3 and 11 years.
Compensation: YesWe are looking for children ages 6-12 with Autism, Asperger’s Syndrome, or PPD-NOS.
Compensation: YesVisit this investigator's people page to list all of their studies together.
615-322-8240, kc@vanderbilt.edu
(Quick Guide), (People Pages), (Family Outreach)
Address, Map, Phone, Email
We're always trying to improve this website. Your input really helps!
Take a brief survey
Vanderbilt Kennedy Center © 2013
Policies and Procedures |
Site Map
